We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Blake Forman

Blake Forman profile page

Senior Science Writer

 at Technology Networks

Blake pens and edits breaking news, articles and features on a broad range of scientific topics with a focus on drug discovery and biopharma. Blake earned an honors degree in chemistry from the University of Surrey, which involved a placement year at the Medicines and Healthcare products Regulatory Agency (MHRA) laboratory, where he developed new pharmaceutical testing methods. Blake also holds an MSc in chemistry from the University of Southampton. His research project focused on the synthesis of novel fluorescent dyes often used as chemical/bio-sensors and as photosensitizers in photodynamic therapy. Blake held several editorial-based roles before joining Technology Networks in 2024.


Education

University of Surrey  

University of Southampton  


Areas of Expertise

Pharmacology
Pharmacovigilance
Analytical Chemistry
Mass Spectrometry
Drug Discovery
Science Communication

Got a Question for Blake Forman?

Get in touch using the contact form linked here and we'll get back to you shortly.



Content Written By, Reviewed By, or Featuring Blake Forman
Total: 198
White pills on top of MRI scans of the human brain, representing neurotherapeutics.
Article

“We Have Solved the Issue of Crossing the BBB”: What’s Next for Neurotherapeutics?

Dr. Maarten Dewilde, an associate professor at KU Leuven, sat down with Technology Networks to discuss molecular engineering approaches that have proven effective in improving the transport of biologics to the brain and their retention in the CNS.
A tumor in yellow being attacked by T cells in blue, representing cancer immunotherapy.
Article

Postbiotics Found To Promote Anti-Cancer Immune Function

Dr. Maik Luu discusses how postbiotics can be used to reprogram CAR T cells to promote anti-tumor function and what further research is needed to bring probiotic-boosted therapies to the clinic.
An illustration of a conical flask made out of leaves on a desk, representing sustainability in pharma.
Article

Large Pharma Companies Make Progress Towards Net Zero, But Start-Ups Struggle Behind

Whilst carbon intensity is beginning to decline among the largest biotech and pharma companies, My Green Lab's 2025 Carbon Impact report warns that more must be done to align the entire value chain with emission reductions.
Close-up of highly venomous western green mamba snake coiled between branches.
Article

The Universal Antivenom That Could Combat the World's Deadliest Snakebites

Research efforts are ongoing to develop safer, broad-spectrum antivenoms. Technology Networks sat down with Dr. Andreas Laustsen-Kiel to learn more about a novel antivenom capable of protecting against Africa's deadliest snakes.
A gloved hand holds a test tube containing a pink liquid with a DNA double helix in the background.
Industry Insight

Designing Synthetic Gene Promoters for Gene Therapy Success

Technology Networks spoke with Dr. David James, professor of bioprocess engineering at the University of Sheffield and co-founder and chief scientific officer at SynGenSys, to learn more about the importance of synthetic promoter design.
A researcher loading vials of sample into a mass spectrometer.
Industry Insight

AS-MS Overcomes Membrane Protein Screening Challenges

In this interview, Dr. Renaud Prudent, scientific director at Edelris, discusses how AS-MS can be utilized as a high-throughput screening technology for identifying membrane protein hits.
AI-driven multiomics in drug discovery depicted with a digital pill and a circuit in the background.
Article

AI-Driven Multiomics Is Set To Transform Drug Discovery – Here’s How

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data integration.
Orange and white drug capsule in front of a blue and white DNA double helix and ball and stick models.
Industry Insight

Digital PCR Innovations Poised To Transform Drug Discovery

In this interview, Dr. Robert Beal discusses how advances in digital polymerase chain reaction technologies are reshaping research workflows.
A doctor prescribing medication with a bottle of pills and model of a human brain on the desk, representing OCD treatments.
Industry Insight

The Future of OCD Treatments With Dr. Nick Sireau

By harnessing advances in imaging technology and precision medicine, Serenatis Bio is hoping to transform the landscape of OCD treatments by targeting the root neurological causes of the disorder.
Neurons in the brain with plaques associated with Alzheimer's disease.
Article

This Fluorescent Probe Could Help Distinguish Alzheimer’s From Aging

Discover how a novel fluorescent probe, capable of probing early oligomeric pathology in neurodegenerative disease, could aid in the diagnosis of Alzheimer’s disease.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter